GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » EPS without NRI

Masimo (Masimo) EPS without NRI

: $2.90 (TTM As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Masimo's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $1.25. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $2.90.

During the past 12 months, Masimo's average earnings per share (NRI) Growth Rate was -19.90% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -21.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -10.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Masimo's EPS without NRI or its related term are showing as below:

MASI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -42.3   Med: 7.9   Max: 39.2
Current: -21.2

During the past 13 years, Masimo's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 39.20% per year. The lowest was -42.30% per year. And the median was 7.90% per year.

MASI's 3-Year EPS without NRI Growth Rate is ranked worse than
82.1% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 10.05 vs MASI: -21.20

Masimo's EPS (Diluted) for the three months ended in Dec. 2023 was $0.63. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.51.

Masimo's EPS (Basic) for the three months ended in Dec. 2023 was $0.64. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.54.


Masimo EPS without NRI Historical Data

The historical data trend for Masimo's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.45 4.09 4.01 2.50 2.01

Masimo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.40 0.62 0.63 1.25

Competitive Comparison

For the Medical Devices subindustry, Masimo's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo PE Ratio without NRI Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Masimo's PE Ratio without NRI falls into.



Masimo EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Masimo  (NAS:MASI) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Masimo EPS without NRI Related Terms

Thank you for viewing the detailed overview of Masimo's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo (Masimo) Business Description

Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Executives
Rolf A Classon director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey other: Director by deputization POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani director, officer: CEO and Chairman of the Board 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi officer: SVP, Chief Accounting Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi officer: COO, Consumer Division C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy officer: President, Consumer 1 VIPER WAY, VISTA CA 92081
Adam Mikkelson director C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy officer: EVP BUS DEV C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young officer: EVP & Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan officer: EVP & GENERAL COUNSEL 40 PARKER, IRVINE CA 92618
Craig B Reynolds director 1046 MIDDLEBROOK WAY, KENESAW GA 30144

Masimo (Masimo) Headlines

From GuruFocus